http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106554954-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| filingDate | 2015-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106554954-B |
| titleOfInvention | In vivo efficacy evaluation method of EV71 vaccine and antiviral drug screening method |
| abstract | The invention relates to an in vivo efficacy evaluation method and an antiviral drug screening method of EV71 vaccine, and particularly relates to the field of biology. More specifically, the invention establishes a sensitive, safe and convenient EV71 vaccine efficacy in-vivo evaluation system consisting of an animal model, a pseudovirus and in-vivo imaging, and provides a new method for the quality control and evaluation of the existing vaccine and the development of a novel vaccine; the method can also be used for screening EV71 related antiviral drugs. |
| priorityDate | 2015-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 32.